A
Aligos Therapeutics, Inc. (ALGS)
NCM – Real Time Price. Currency in USD
5.57
+0.07 (1.27%)
At close: Jun 26, 2026, 4:00 PM EDT
5.60
+0.03 (0.54%)
After-hours: Jun 26, 2026, 6:44 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
5.57
+0.07 (1.27%)
At close: Jun 26, 2026, 4:00 PM EDT
5.60
+0.03 (0.54%)
After-hours: Jun 26, 2026, 6:44 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $30.2M significantly exceed its total debt $4.4M, ensuring strong financial flexibility
Total current assets $59.6M exceed Total current liabilities $23.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$23.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.56 | 6.05 | 10 | |
| Quick ratio | 2.56 | 5.63 | 10 | |
| Debt to Equity | 0.14 | 0.30 | 9.0 | |
| Debt to Assets | 0.07 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 14M | 16M | 4M | 2M | 5M |
| Gross Profit | 10M | 12M | 1M | 1M | 4M |
| Operating Income | -98M | -87M | -89M | -88M | -96M |
| Net Income | -96M | -88M | -131M | -24M | -90M |
| EBITDA | -94M | -84M | -87M | -87M | -95M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 1554.15 | 34.69 | 10 |
| Next quarter | -19.03 | 27.46 | 5.5 |
| Current year | 810.85 | -187.75 | 5.5 |
| Next year | -78.48 | 36.27 | 5.5 |
| Weighted average score | 6.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 1574.56 | -15.88 | -15.7 | -6.22 | 3.3 |
| Y/Y | 809.97 | -153.46 | -4.73 | -10.7 | 3.3 |
| 3y average | -35.83 | 13.54 | 55.42 | -1.07 | 5.0 |
| 5y average | 222.11 | 9.51 | 53.35 | -4.96 | 6.8 |
| Weighted average score | 4.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |